Hummingbird and MD Anderson collaborate to advance VISTA antagonist antibody, HMBD-002 July 13, 2021 No Comments
Safety monitoring committee recommends continuation of phase IIb study of RV-001 in prostate cancer July 12, 2021 No Comments
Dosing begins in phase I study in China of IBI-323 for advanced malignant tumors July 12, 2021 No Comments
Results of phase I trial of CRAd-S-pk7 oncolytic adenovirus delivered by neural stem cells in glioma July 12, 2021 No Comments
Evaxion presents phase I/IIa data for its cancer immunotherapy candidates, EVX-01 and EVX-02 July 9, 2021 No Comments